AstraZeneca unifies global share structure with move to New York Stock Exchange
AstraZeneca announced a move to the New York Stock Exchange to unify its listing structure. The transition simplifies trading across major global markets.
Insights:
AstraZeneca PLC announced on January 20, 2026, that it will delist its American Depositary Shares and debt securities from Nasdaq in the US 
US. This move is part of a shareholder-approved plan to unify the company's share listing structure across global markets. The delisting and subsequent direct listing on the New York Stock Exchange are scheduled to become effective after the market close on January 30, 2026.
US. This move is part of a shareholder-approved plan to unify the company's share listing structure across global markets. The delisting and subsequent direct listing on the New York Stock Exchange are scheduled to become effective after the market close on January 30, 2026.
